Consolidated Statements of Operations - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2020	Dec. 31, 2019
Operating expense:
Research & development	$ 11,982	$ 3,878
General & administrative	22,462	3,952
Total operating expenses	34,444	7,830
Operating loss	(34,444)	(7,830)
Other income, net
Interest income, net	(466)
Total other income, net	(466)
Net Loss	$ (33,978)	$ (7,830)
Weighted Average Shares Outstanding, basic and diluted	7,233,913	2,577,493
Net loss per share, basic and diluted	$ (4.70)	$ (3.04)